Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Toxicol Mech Methods ; 28(8): 563-572, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29768075

RESUMO

Mice and other rodents are typically utilized for chemical warfare nerve agent research. Rodents have large amounts of carboxylesterase in their blood, while humans do not. Carboxylesterase nonspecifically binds to and detoxifies nerve agent. The presence of this natural bioscavenger makes mice and other rodents poor models for studies identifying therapeutics to treat humans exposed to nerve agents. To obviate this problem, a serum carboxylesterase knockout (Es1 KO) mouse was created. In this study, Es1 KO and wild type (WT) mice were assessed for differences in gene expression, nerve agent (soman; GD) median lethal dose (MLD) values, and behavior prior to and following nerve agent exposure. No expression differences were detected between Es1 KO and WT mice in more than 34 000 mouse genes tested. There was a significant difference between Es1 KO and WT mice in MLD values, as the MLD for GD-exposed WT mice was significantly higher than the MLD for GD-exposed Es1 KO mice. Behavioral assessments of Es1 KO and WT mice included an open field test, a zero maze, a Barnes maze, and a sucrose preference test (SPT). While sex differences were observed in various measures of these tests, overall, Es1 KO mice behaved similarly to WT mice. The two genotypes also showed virtually identical neuropathological changes following GD exposure. Es1 KO mice appear to have an enhanced susceptibility to GD toxicity while retaining all other behavioral and physiological responses to this nerve agent, making the Es1 KO mouse a more human-like model for nerve agent research.


Assuntos
Comportamento Animal/efeitos dos fármacos , Hidrolases de Éster Carboxílico/sangue , Aprendizagem em Labirinto/efeitos dos fármacos , Agentes Neurotóxicos/toxicidade , Soman/toxicidade , Animais , Hidrolases de Éster Carboxílico/genética , Feminino , Perfilação da Expressão Gênica , Dose Letal Mediana , Masculino , Camundongos Endogâmicos C57BL , Camundongos Knockout , Transcriptoma/efeitos dos fármacos
2.
J Alzheimers Dis ; 10(4): 417-22, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17183154

RESUMO

Recent studies from our laboratories and others suggest that calorie restriction (CR) may benefit Alzheimer's disease (AD) by preventing amyloid-beta (Abeta) neuropathology in the mouse models of AD. Moreover, we found that promotion of the NAD+-dependent SIRT1 mediated deacetylase activity, a key regulator in CR extension of life span, may be a mechanism by which CR influences AD-type neuropathology. In this study we continued to explore the role of CR in AD-type brain amyloidosis in Squirrel monkeys (Saimiri sciureus). Monkeys were maintained on the normal and CR diets throughout the entire lifespan until they died of natural causes. We found that 30% CR resulted in reduced contents of Abeta1-40 and Abeta1-42 peptides in the temporal cortex of Squirrel monkeys, relative to control (CON) fed monkeys. The decreased contents of cortical Abeta peptide inversely correlated with SIRT1 protein concentrations in the same brain region; no detectable change in total full-length amyloid-beta protein precursor (AbetaPP) level was found. Most interestingly, we found that 30% CR resulted in a select elevation of alpha- but not beta- or gamma- secretase activity which coincided with decreased ROCK1 protein content in the same brain region, relative to CON group. Collectively, the study suggests that investigation of the role of CR in non-human primates may provide a valuable approach for further clarifying the role of CR in AD.


Assuntos
Doença de Alzheimer/patologia , Amiloidose/patologia , Restrição Calórica , Secretases da Proteína Precursora do Amiloide/metabolismo , Peptídeos beta-Amiloides/metabolismo , Precursor de Proteína beta-Amiloide/metabolismo , Animais , Encéfalo/patologia , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Masculino , Proteínas Serina-Treonina Quinases/metabolismo , Saimiri , Sirtuína 1 , Sirtuínas/metabolismo , Quinases Associadas a rho
3.
Diabetes ; 51(9): 2826-32, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12196477

RESUMO

We examined the ability of pyridoxamine (PM), an inhibitor of formation of advanced glycation end products (AGEs) and lipoxidation end products (ALEs), to protect against diabetes-induced retinal vascular lesions. The effects of PM were compared with the antioxidants vitamin E (VE) and R-alpha-lipoic acid (LA) in streptozotocin-induced diabetic rats. Animals were given either PM (1 g/l drinking water), VE (2,000 IU/kg diet), or LA (0.05%/kg diet). After 29 weeks of diabetes, retinas were examined for pathogenic changes, alterations in extracellular matrix (ECM) gene expression, and accumulation of the immunoreactive AGE/ALE N( epsilon )-(carboxymethyl)lysine (CML). Acellular capillaries were increased more than threefold, accompanied by significant upregulation of laminin immunoreactivity in the retinal microvasculature. Diabetes also increased mRNA expression for fibronectin (2-fold), collagen IV (1.6-fold), and laminin beta chain (2.6-fold) in untreated diabetic rats compared with nondiabetic rats. PM treatment protected against capillary drop-out and limited laminin protein upregulation and ECM mRNA expression and the increase in CML in the retinal vasculature. VE and LA failed to protect against retinal capillary closure and had inconsistent effects on diabetes-related upregulation of ECM mRNAs. These results indicate that the AGE/ALE inhibitor PM protected against a range of pathological changes in the diabetic retina and may be useful for treating diabetic retinopathy.


Assuntos
Diabetes Mellitus Experimental/tratamento farmacológico , Retinopatia Diabética/prevenção & controle , Produtos Finais de Glicação Avançada/antagonistas & inibidores , Piridoxamina/uso terapêutico , Animais , Capilares/metabolismo , Capilares/patologia , Retinopatia Diabética/patologia , Matriz Extracelular/metabolismo , Feminino , Laminina/metabolismo , Lisina/análogos & derivados , Lisina/metabolismo , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Retina/metabolismo , Vasos Retinianos/metabolismo , Vasos Retinianos/patologia
4.
Behav Neurosci ; 118(3): 514-25, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15174929

RESUMO

The role of the claustrum in Pavlovian heart rate (HR) conditioning was studied in the rabbit (Oryctolagus cuniculus) by (a) mapping claustral projections to the prefrontal cortex (PFC), (b) recording claustral single-unit discharge to sensory stimulation and conditioning stimuli during HR conditioning, and (c) assessing the effects of claustral damage on HR conditioning. Contralateral and ipsilateral claustral projections to the PFC were found. Claustral cells responded to nonsignal stimulation with increased discharge and also showed conditioned stimulus-evoked increases in discharge during Pavlovian HR conditioning. Moreover, claustral lesions diminished the magnitude of the HR-conditioned response without affecting the cardiac-orienting response to the conditioned stimulus or the cardiac-unconditioning response to the unconditioned stimulus, suggesting a role for the claustrum in associative learning.


Assuntos
Gânglios da Base/fisiologia , Condicionamento Clássico/fisiologia , Eletrofisiologia , Frequência Cardíaca/fisiologia , Potenciais de Ação/fisiologia , Potenciais de Ação/efeitos da radiação , Análise de Variância , Animais , Gânglios da Base/citologia , Gânglios da Base/lesões , Comportamento Animal , Contagem de Células , Relação Dose-Resposta à Radiação , Eletrólise/efeitos adversos , Eletromiografia , Eletrochoque/métodos , Feminino , Corantes Fluorescentes/metabolismo , Masculino , Vias Neurais , Neuroanatomia , Neurônios/classificação , Neurônios/fisiologia , Estimulação Física/métodos , Córtex Pré-Frontal/anatomia & histologia , Córtex Pré-Frontal/metabolismo , Córtex Pré-Frontal/fisiologia , Coelhos , Reflexo/fisiologia , Reflexo/efeitos da radiação , Estilbamidinas/metabolismo
5.
Age (Dordr) ; 34(6): 1453-8, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22037865

RESUMO

Calorie restriction (CR) is a reliable anti-aging intervention that attenuates the onset of a number of age-related diseases, reduces oxidative damage, and maintains function during aging. In the current study, we assessed the effects of CR and other feeding regimens on wound healing in 7-month-old Fischer-344 rats from a larger cohort of rats that had been fed either ad libitum (AL) or 40% calorie restricted based on AL consumption. Rats were assigned to one of three diet groups that received three skin punch wounds along the dorsal interscapular region (12-mm diameter near the front limbs) of the back as follows: (1) CR (n = 8) were wounded and maintained on CR until they healed, (2) AL (n = 5) were wounded and maintained on AL until wound closure was completed, and (3) CR rats were refed (RF, n = 9) AL for 48 h prior to wounding and maintained on AL until they healed. We observed that young rats on CR healed more slowly while CR rats refed for 48 h prior to wounding healed as fast as AL fed rats, similar to a study reported in aged CR and RF mice (Reed et al. 1996). Our data suggest that CR subjects, regardless of age, fail to heal well and that provision of increased nutrition to CR subjects prior to wounding enhances the healing process.


Assuntos
Ingestão de Energia/fisiologia , Privação de Alimentos/fisiologia , Pele/lesões , Cicatrização/fisiologia , Animais , Ingestão de Energia/genética , Metabolismo Energético/genética , Metabolismo Energético/fisiologia , Matriz Extracelular/genética , Matriz Extracelular/fisiologia , Canais Iônicos/genética , Canais Iônicos/fisiologia , Masculino , Proteínas Mitocondriais/genética , Proteínas Mitocondriais/fisiologia , Estresse Oxidativo/genética , Estresse Oxidativo/fisiologia , Coativador 1-alfa do Receptor gama Ativado por Proliferador de Peroxissomo , Proteínas de Ligação a RNA/genética , Proteínas de Ligação a RNA/fisiologia , Ratos , Ratos Endogâmicos F344 , Sirtuína 1/genética , Sirtuína 1/fisiologia , Transativadores/genética , Fatores de Transcrição/genética , Fatores de Transcrição/fisiologia , Proteína Desacopladora 1 , Cicatrização/genética
6.
Neurosci Lett ; 464(3): 184-7, 2009 Oct 30.
Artigo em Inglês | MEDLINE | ID: mdl-19699265

RESUMO

Caloric restriction (CR) mitigates neurological damage arising from aging and a variety of other sources, including neuropathology in young adult mice that express single and double transgenic (tg) mutations associated with Alzheimer disease (AD). To evaluate the potential of CR to protect against relatively heavy AD-type pathology, middle-aged (13-14-month-old) mice that co-express two mutations related to familial AD, amyloid precursor protein (APP) and presenilin 1 (PS1), were fed balanced diets with 40% fewer calories than ad libitum-fed controls. Following 18 weeks of treatment, mice were killed and brains were processed for quantification of total volume of amyloid-beta (Abeta) in the hippocampal formation and the overlying neocortex. Computerized stereology confirmed that CR reduced the total Abeta volume by about one-third compared to that in age-matched controls. Thus, CR appears to attenuate the accumulation of AD-type neuropathology in two cortical brain regions of middle-aged dtg APP/PS1 mice. These findings support the view that CR could be a potentially effective, non-pharmacology strategy for reducing relatively heavy Abeta deposition in older adult dtg APP/PS1 mice, and possibly afford similar protection against the onset and progression of AD in older adult humans.


Assuntos
Envelhecimento/metabolismo , Peptídeos beta-Amiloides/metabolismo , Restrição Calórica , Hipocampo/metabolismo , Neocórtex/metabolismo , Animais , Masculino , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Camundongos Mutantes
7.
Science ; 305(5689): 1423-6, 2004 Sep 03.
Artigo em Inglês | MEDLINE | ID: mdl-15353793

RESUMO

Progress in gerontological research has been promoted through the use of numerous animal models, which have helped identify possible mechanisms of aging and age-related chronic diseases and evaluate possible interventions with potential relevance to human aging and disease. Further development of nonhuman primate models, particularly rhesus monkeys, could accelerate this progress, because their closer genetic relationship to humans produces a highly similar aging phenotype. Because the relatively long lives of primates increase the administrative and economic demands on research involving them, new emphasis has emerged on increasing the efficient use of these valuable resources through cooperative, interdisciplinary research.


Assuntos
Envelhecimento , Macaca mulatta/fisiologia , Modelos Animais , Animais , Biomarcadores , Restrição Calórica , Doença Crônica , Estudos Transversais , Modelos Animais de Doenças , Feminino , Cardiopatias/fisiopatologia , Cardiopatias/terapia , Humanos , Estudos Longitudinais , Masculino , Neoplasias/fisiopatologia , Neoplasias/terapia
8.
J Biol Chem ; 278(43): 42012-9, 2003 Oct 24.
Artigo em Inglês | MEDLINE | ID: mdl-12923193

RESUMO

Maillard or browning reactions between reducing sugars and protein lead to formation of advanced glycation end products (AGEs) and are thought to contribute to the pathogenesis of diabetic complications. AGE inhibitors such as aminoguanidine and pyridoxamine (PM) inhibit both the formation of AGEs and development of complications in animal models of diabetes. PM also inhibits the chemical modification of protein by advanced lipoxidation end products (ALEs) during lipid peroxidation reactions in vitro. We show here that several PM adducts, formed in incubations of PM with linoleate and arachidonate in vitro, are also excreted in the urine of PM-treated animals. The PM adducts N-nonanedioyl-PM (derived from linoleate), N-pentanedioyl-PM, N-pyrrolo-PM, and N-(2-formyl)-pyrrolo-PM (derived from arachidonate), and N-formyl-PM and N-hexanoyl-PM (derived from both fatty acids) were quantified by liquid chromatography-mass spectrometry analysis of rat urine. Levels of these adducts were increased 5-10-fold in the urine of PM-treated diabetic and hyperlipidemic rats, compared with control animals. We conclude that the PM functions, at least in part, by trapping intermediates in AGE/ALE formation and propose a mechanism for PM inhibition of AGE/ALE formation involving cleavage of alpha-dicarbonyl intermediates in glycoxidation and lipoxidation reactions. We also conclude that ALEs derived from polyunsaturated fatty acids are increased in diabetes and hyperlipidemia and may contribute to development of long term renal and vascular pathology in these diseases.


Assuntos
Ácidos Graxos Insaturados/metabolismo , Peroxidação de Lipídeos , Piridoxamina/metabolismo , Animais , Ácido Araquidônico/química , Glicemia/efeitos dos fármacos , Complicações do Diabetes , Diabetes Mellitus/urina , Ácidos Graxos Insaturados/química , Ácidos Graxos Insaturados/urina , Feminino , Hiperlipidemias/etiologia , Hiperlipidemias/urina , Ácido Linoleico/química , Piridoxamina/química , Piridoxamina/farmacologia , Piridoxamina/urina , Ratos , Ratos Sprague-Dawley , Ratos Zucker , Triglicerídeos/sangue
9.
Kidney Int ; 63(6): 2123-33, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12753299

RESUMO

BACKGROUND: In previous studies, pyridoxamine (PM) limited the formation of advanced glycation end products (AGEs) and development of nephropathy in streptozotocin-diabetic rats without affecting glycemic control. However, the lipid-lowering effects of PM and the correlation of plasma cholesterol and triglycerides with AGEs in skin collagen suggested that lipids might be an important source of AGEs in the diabetic rat. This study addresses the effects of hyperlipidemia on formation of advanced glycation and lipoxidation end products (AGE/ALEs) and the effects of PM on hyperlipidemia, hypertension, AGE/ALE formation, and development of nephropathy in the nondiabetic, Zucker obese rat. METHODS: Three groups of Zucker rats were studied: lean (Fa/fa), untreated fatty (fa/fa), and fa/fa treated with PM (2 g/L drinking water). Blood pressure, plasma lipids and creatinine, and urinary albumin were measured monthly. AGE/ALEs were measured in skin collagen by high-performance liquid chromatography (HPLC) and gas chromatography/mass spectrometry (GC/MS). Changes in wall thickness of the aorta and renal arterioles were evaluated by light microscopy. RESULTS: AGE/ALEs formation was increased two- to threefold in skin collagen of obese versus lean rats. PM inhibited the increases in AGE/ALEs in collagen, and significantly decreased the rise in plasma triglycerides, cholesterol, and creatinine, corrected hypertension and thickening of the vascular wall, and nearly normalized urinary protein and albumin excretion in Zucker fa/fa rats. CONCLUSION: Lipids are an important source of chemical modification of tissue proteins, even in the absence of hyperglycemia. PM inhibited AGE/ALE formation and hyperlipidemia and protected against renal and vascular pathology in a nondiabetic model.


Assuntos
Arginina/análogos & derivados , Produtos Finais de Glicação Avançada/antagonistas & inibidores , Hiperlipidemias/tratamento farmacológico , Hipertensão/prevenção & controle , Nefropatias/prevenção & controle , Lisina/análogos & derivados , Piridoxamina/farmacologia , Animais , Aorta/patologia , Arginina/antagonistas & inibidores , Arginina/sangue , Glicemia , Pressão Sanguínea , Colágeno/metabolismo , Feminino , Produtos Finais de Glicação Avançada/sangue , Hiperlipidemias/sangue , Hiperlipidemias/patologia , Hipertensão/sangue , Hipertensão/patologia , Rim/patologia , Rim/fisiologia , Nefropatias/sangue , Nefropatias/patologia , Lisina/antagonistas & inibidores , Lisina/sangue , Ratos , Ratos Zucker , Pele/metabolismo , Aumento de Peso/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA